Vaccination: The HPV vaccine is included in the national immunization schedule and is administered free of charge to girls and boys aged 11. It is also available to other at-risk populations. Vaccination protects against the most dangerous types of HPV, significantly reducing the risk of developing cancers related to this virus.
Secondary prevention: This relies on the early detection of lesions that may become cancerous. Two main tests are used for this purpose:
the Pap test (cervical smear): it detects abnormal cells in the cervix before they become cancerous. It is recommended to have it regularly starting at age 25.
The HPV test: it detects the presence of high-risk types of HPV in the cervix. It complements the Pap test and is recommended starting at age 30.
If the HPV test is positive, it means that the person is a carrier of the virus, but not necessarily that they have developed cancer. In this case, the Pap test can determine if there are lesions that require treatment.
The importance of a comprehensive approach:
Preventing cervical cancer and other HPV-related diseases requires a comprehensive approach combining education, vaccination, medical screening, and timely access to appropriate treatments. We have effective tools to significantly reduce the impact of HPV, but it is essential that information reaches everyone and that the importance of health autonomy is encouraged.

Commitment to our health and the health of our community is essential to slowing the spread of HPV and preventing serious illness. Individual and collective responsibility plays a fundamental role in eradicating this virus and its consequences. Information is our best tool for acting promptly and making informed decisions about our health.